IRF4 and B-cell non-Hodgkin lymphoma: Therefore, Spi-B may be involved in a unique regulatory network where it is more frequently associated with IRF4 in B cell lymphomas, and may be directed to these sites by IRF4 or function to alter IRF4 occupancy within the genome.